Latest Insider Transactions at Pfizer Inc (PFE)
This section provides a real-time view of insider transactions for Pfizer Inc (PFE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PFIZER INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PFIZER INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Rady A Johnson Executive Vice President |
SELL
Bona fide gift
|
Direct |
661
-1.03%
|
-
|
|
Nov 09
2020
|
Albert Bourla Chairman & CEO |
SELL
Open market or private sale
|
Direct |
132,508
-62.87%
|
$5,432,828
$41.94 P/Share
|
|
Nov 09
2020
|
Sally Susman Executive Vice President |
SELL
Open market or private sale
|
Direct |
43,662
-28.77%
|
$1,790,142
$41.94 P/Share
|
|
Aug 06
2020
|
Ronald E Blaylock Director |
BUY
Open market or private purchase
|
Direct |
13,000
+21.28%
|
$494,000
$38.57 P/Share
|
|
Jun 05
2020
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
2,181
-22.43%
|
$78,516
$36.13 P/Share
|
|
May 18
2020
|
Mikael Dolsten President R&D |
SELL
Open market or private sale
|
Direct |
95,353
-5.22%
|
$3,528,061
$37.79 P/Share
|
|
Apr 29
2020
|
John D Young Group President |
SELL
Bona fide gift
|
Direct |
7,910
-1.84%
|
-
|
|
Apr 29
2020
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
2,181
-18.44%
|
$82,878
$38.35 P/Share
|
|
Apr 29
2020
|
Rady A Johnson Executive Vice President |
SELL
Open market or private sale
|
Direct |
13,125
-17.03%
|
$498,750
$38.36 P/Share
|
|
Apr 29
2020
|
Dawn Rogers Executive Vice President |
SELL
Open market or private sale
|
Direct |
13,000
-72.94%
|
$494,000
$38.13 P/Share
|
|
Apr 29
2020
|
Douglas M Lankler Executive Vice President |
SELL
Open market or private sale
|
Direct |
65,000
-23.85%
|
$2,405,000
$37.92 P/Share
|
|
Feb 28
2020
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,819
-5.22%
|
$809,846
$34.93 P/Share
|
|
Feb 28
2020
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,135
+12.46%
|
$894,645
$27.37 P/Share
|
|
Feb 28
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
18,669
-6.8%
|
$634,746
$34.93 P/Share
|
|
Feb 28
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
27,422
+16.31%
|
$740,394
$27.37 P/Share
|
|
Feb 28
2020
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
130,834
-12.41%
|
$4,448,356
$34.93 P/Share
|
|
Feb 28
2020
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
173,675
+23.8%
|
$4,689,225
$27.37 P/Share
|
|
Feb 28
2020
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
39,446
-12.81%
|
$1,301,718
$33.42 P/Share
|
|
Feb 28
2020
|
Michael Goettler Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,224
-16.31%
|
$551,616
$34.93 P/Share
|
|
Feb 28
2020
|
Michael Goettler Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,852
+30.11%
|
$617,004
$27.37 P/Share
|
|
Feb 28
2020
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,891
-6.34%
|
$370,294
$34.93 P/Share
|
|
Feb 28
2020
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,996
+15.39%
|
$431,892
$27.37 P/Share
|
|
Feb 28
2020
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
29,266
-8.81%
|
$995,044
$34.93 P/Share
|
|
Feb 28
2020
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
38,848
+18.38%
|
$1,048,896
$27.37 P/Share
|
|
Feb 28
2020
|
Alexander R Mackenzie Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
29,357
-10.99%
|
$998,138
$34.93 P/Share
|
|
Feb 28
2020
|
Alexander R Mackenzie Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
37,934
+21.29%
|
$1,024,218
$27.37 P/Share
|
|
Feb 28
2020
|
Dawn Rogers Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
12,222
-22.05%
|
$415,548
$34.93 P/Share
|
|
Feb 28
2020
|
Dawn Rogers Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,824
+37.24%
|
$481,248
$27.37 P/Share
|
|
Feb 28
2020
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
70,738
-17.15%
|
$2,405,092
$34.93 P/Share
|
|
Feb 28
2020
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
91,408
+29.12%
|
$2,468,016
$27.37 P/Share
|
|
Feb 28
2020
|
John D Young Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
75,745
-7.76%
|
$2,575,330
$34.93 P/Share
|
|
Feb 28
2020
|
John D Young Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,548
+16.62%
|
$2,714,796
$27.37 P/Share
|
|
Feb 26
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
21,671
-5.47%
|
$758,485
$35.41 P/Share
|
|
Feb 26
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,797
+2.74%
|
-
|
|
Feb 26
2020
|
Loretta V Cangialosi Sr. Vice President, Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
24,155
+15.55%
|
$821,270
$34.59 P/Share
|
|
Feb 26
2020
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
74,726
-13.94%
|
$2,615,410
$35.76 P/Share
|
|
Feb 26
2020
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,567
+24.4%
|
$3,011,278
$34.59 P/Share
|
|
Feb 26
2020
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
37,792
-5.62%
|
$1,284,928
$34.72 P/Share
|
|
Feb 26
2020
|
Mikael Dolsten President R&D |
BUY
Grant, award, or other acquisition
|
Direct |
45,566
+11.64%
|
-
|
|
Feb 26
2020
|
Frank A Damelio Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
145,477
-9.71%
|
$5,091,695
$35.41 P/Share
|
|
Feb 26
2020
|
Frank A Damelio Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
45,566
+7.95%
|
-
|
|
Feb 26
2020
|
Frank A Damelio Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
144,928
+23.11%
|
$4,927,552
$34.59 P/Share
|
|
Feb 26
2020
|
Michael Goettler Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,537
-13.45%
|
$648,795
$35.41 P/Share
|
|
Feb 26
2020
|
Michael Goettler Group President |
BUY
Grant, award, or other acquisition
|
Direct |
3,164
+6.1%
|
-
|
|
Feb 26
2020
|
Michael Goettler Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,129
+30.64%
|
$684,386
$34.59 P/Share
|
|
Feb 26
2020
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
12,229
-19.47%
|
$428,015
$35.76 P/Share
|
|
Feb 26
2020
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
14,493
+30.86%
|
$492,762
$34.59 P/Share
|
|
Feb 26
2020
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
31,757
-10.76%
|
$1,111,495
$35.41 P/Share
|
|
Feb 26
2020
|
Rady A Johnson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
10,506
+9.2%
|
-
|
|
Feb 26
2020
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
33,414
+26.39%
|
$1,136,076
$34.59 P/Share
|